Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease

Drugs - United Kingdom
doi 10.1007/s40265-018-0950-2
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hyperphosphatemia in Chronic Kidney Disease

Medical Council
2019English

NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in Chronic Kidney Disease

Kidney International Reports
Nephrology
2018English

Gastrointestinal Disorders and Chronic Kidney Disease.

International Journal of Advanced Research
2016English

The Management of Hyperphosphatemia by Lanthanum Carbonate in Chronic Kidney Disease Patients

International Journal of Nephrology and Renovascular Disease
Nephrology
2012English

Hyperphosphatemia in Chronic Kidney Disease: Patient Characteristics and Dialysis Mortality During the First Year of Dialysis

Journal of Nephrology & Therapeutics
2012English

Bioactive Food and Exercise in Chronic Kidney Disease: Targeting the Mitochondria

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2018English

Targeting the Transcription Factor Nrf2 to Ameliorate Oxidative Stress and Inflammation in Chronic Kidney Disease

Kidney International
Nephrology
2013English

Strategies for Phosphate Control in Patients With Chronic Kidney Disease

Kidney International Reports
Nephrology
2019English

Rescue Therapy With Tanshinone IIA Hinders Transition of Acute Kidney Injury to Chronic Kidney Disease via Targeting GSK3β

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy